tirzepatide renal impairment Effects of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial SURPASS-4: Tirzepatide slows kidney disease

Laursen MF, Sakanaka M, von Burg N, et al

GLP-1s and oral health research Although the technology is still years away from potential commercialization, the announcement highlights how rapidly the widespread adoption of GLP-1 medications is creating new questionsnot only for the medical aesthetics industry but also for dentistry, where researchers are only beginning to understand the drugs effects on oral health

Athletes may notice less postworkout fatigue and a quicker return to baseline when programs, sleep, and nutrition are in place

Pharmacological management of obesity: an endocrine society clinical practice guideline

IR Contact: [email protected]